• Serotonin and nitric oxide interact at different levels to control behavior.
Introduction
An interaction between serotonin (5-HT) and the nitrergic system has been observed in the brain at the molecular [1, 2] , systems [3, 4] , and behavioral [5] [6] [7] [8] [9] levels. This complex interaction involves both nitric oxide (NO) mediation of 5-HT release/uptake [9] [10] [11] [12] as well as the 5-HTergic mediation of NO activity [1, 13, 14] . In this sense, chronic treatment with 5-HT 1A receptor (5-HT 1A R) agonists has been shown to decrease anxiety-like behavior in a NO-dependent way [6] , and activation of the 5-HT 1A R decreases NMDA receptor-mediated increases in NO production in cortical slices [13] . While the role of the 5-HT 1A R in anxiety-like behavior is relatively well-established, the participation of 5-HT 1B receptors (5-HT 1B R) is emergent; 5-HT 1B R knockout mice show increased reactivity to novelty and decreased anxiety-like behavior [15] , while zebrafish treated with 5-HT 1B R antagonists show decreased reactivity to novelty [16, 17] . Elsewhere, we have shown that the anxiolytic-like effect of 5-HT 1A R antagonists in zebrafish is blocked by pre-treatment with the nitric oxide synthase (NOS) inhibitor l-N G -nitroarginine methyl ester (l-NAME) [18] ; in the present work, we analyzed whether the behavioral effects of the 5-HT 1B R inverse agonist SB 224,289 in zebrafish are also mediated by NOS.
Materials and methods
47 adult zebrafish from the lof phenotype were acquired in a local aquarium shop and kept in collective tanks (40 L, 10 animals/2 L) for at least two weeks before experiments begun. Water http://dx.doi.org/10.1016/j.neulet.2014.12.049 0304-3940/© 2014 Elsevier Ireland Ltd. All rights reserved. Table 1 SB224,289 decreases erratic swimming, and this effect is not blocked by L-NAME. Values refer either to mean ± S.E.M. or median ± interquartile range (IQR). *, p < 0.05 vs. Vehicle. Vehicle (n = 9) SB 2.5 mg/kg (n = 8) SB 5.0 mg/kg (n = 9) SB 2.5 mg/kg + NAME (n = 12) SB 5 mg/kg + NAME (n = 12) conditions, housing, and feeding conditions were standardised as per recommendations for zebrafish [19] . Animals were then swiftly and individually removed from the housing tank, cold-anesthetized (17 • C < T < 12 • C) and injected intraperitoneally [20] with either vehicle (DMSO 0.5%) or SB 224,289 (2.5 or 5.0 mg/kg). Another cohort of animals was pre-treated with l-NAME (1 mg/kg) before SB 224,289. 30 min after injection, animals were subjected to the novel tank test [21] ; behavioral variables were defined as per the Zebrafish Behavior Catalog [22] . Data were analyzed using ANOVAs or Kruskal-Wallis tests whenever appropriate, with either Tukey or Bonferroni post-tests whenever p-values < 0.05. Raw data can be downloaded at figshare (doi:10.6084/m9.figshare.1272823).
Results
SB 224,289 dose-dependently decreased bottom-dwelling (F 4,41 = 6.814, p = 0.0003; Fig. 1 Table 1 ). Pre-treatment with l-NAME blocked the effects of SB 224,289 on bottom-dwelling, but not on erratic swimming (Fig. 1,  Table 1 ).
Discussion
The reduction in bottom-dwelling, the main response of adult zebrafish to a novel environment [23, 24] , as well as in erratic swimming, are indicative of reduced anxiety, stress or fear. The results from the present experiment provide a novel mechanism by which serotonin controls behavioral responses to novelty, suggesting an important interaction between the 5-HT 1B receptor and the nitrergic system. The specific mechanism by which NOS inhibition blocks the neotic effects of 5-HT 1B R antagonists in zebrafish is unclear; this interaction could be due to presynaptic effects of NO on 5-HT release or uptake [9] [10] [11] [12] or to a postsynaptic effect, with 5-HT 1B receptor activation increasing NOS activity [25] . Futher experiments are needed to clarify the issue.
